comparemela.com
Home
Live Updates
RQ Bio Launches with Goal to Transform Treatment and Prevention of Viral Infectious Diseases Through Antibody Technologies : comparemela.com
RQ Bio Launches with Goal to Transform Treatment and Prevention of Viral Infectious Diseases Through Antibody Technologies
- UK-based RQ Biotechnology Ltd (RQ Bio) launches with funding from licensing deal with AstraZeneca for RQ Bio's existing early stage monoclonal antibodies (mAbs) against SARS-CoV-2 with payments
Related Keywords
United Kingdom ,
London ,
City Of ,
Mike Westby ,
Gavin Screaton ,
Kostenloser Wertpapierhandel ,
Clare Terlouw ,
Paul Kellam ,
Astrazeneca ,
Oxford University Innovation ,
Linkedin ,
University Of Oxford ,
United Rq Biotechnology Ltd Bio ,
Head Of The Medical Sciences Division ,
Chief Commercial Officer ,
Sanofi Executive ,
Chief Executive Officer ,
United Kingdom Based ,
Centauri Therapeutics ,
Pfizer Rd Executive ,
Virus Genomics ,
Imperial College London ,
Vice President ,
Infectious Diseases ,
Kymab United Kingdom ,
Professor Gavin Screaton ,
Medical Sciences Division ,
Lifearc Ventures ,
Hugo Fry ,
Launches ,
Goal ,
Ransform ,
Treatment ,
Prevention ,
Viral ,
Nfectious ,
Diseases ,
Through ,
Ntibody ,
Technologies ,
comparemela.com © 2020. All Rights Reserved.